Related references
Note: Only part of the references are listed.Advancing the global public health agenda for NAFLD: a consensus statement
Jeffrey Lazarus et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)
A global view of the interplay between non-alcoholic fatty liver disease and diabetes
Norbert Stefan et al.
LANCET DIABETES & ENDOCRINOLOGY (2022)
Association of rs5742612 Polymorphism in the Promoter Region of IGF1 Gene with Nonalcoholic Fatty Liver Disease: A Case-Control Study
Hossein Nobakht et al.
LABORATORY MEDICINE (2022)
Accelerated cardiovascular risk after viral clearance in hepatitis C patients with the NAMPT-rs61330082 TT genotype: An 8-year prospective cohort study
Ming-Ling Chang et al.
VIRULENCE (2021)
Visfatin exacerbates hepatic inflammation and fibrosis in a methionine-choline-deficient diet mouse model
Yu Jung Heo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
The Leu72Met (rs696217 G>T) Polymorphism of the Ghrelin Gene Might Be a Protective Factor for Nonalcoholic Fatty Liver Disease
Seidamir Pasha Tabaeian et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2021)
Does adipose tissue inflammation drive the development of non-alcoholic fatty liver disease in obesity?
Adryana Cordeiro et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2020)
Causes, consequences, and treatment of metabolically unhealthy fat distribution
Norbert Stefan
Lancet Diabetes & Endocrinology (2020)
Visfatin Induces Inflammation and Insulin Resistance via the NF-κB and STAT3 Signaling Pathways in Hepatocytes
Yu Jung Heo et al.
JOURNAL OF DIABETES RESEARCH (2019)
A Complex Relationship between Visfatin and Resistin and microRNA: An In Vitro Study on Human Chondrocyte Cultures
Sara Cheleschi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Gene gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy
M. R. Luizon et al.
PHARMACOGENOMICS JOURNAL (2017)
Correlation between polymorphisms in the visfatin gene and its expression in the serum and coronary artery calcification
L. W. Jin et al.
GENETICS AND MOLECULAR RESEARCH (2016)
Gly972Arg variant of insulin receptor substrate 1 gene and colorectal cancer risk in overweight/obese subjects
Touraj Mahmoudi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2016)
Association of adiponectin receptor 1 gene - 106 C > T variant with susceptibility to colorectal cancer
Touraj Mahmoudi et al.
META GENE (2016)
Severity of Nonalcoholic Fatty Liver Disease and Progression to Cirrhosis Are Associated With Atherogenic Lipoprotein Profile
Mohammad S. Siddiqui et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Prevalence of Insulin Resistance in Subjects with Nonalcoholic Fatty Liver Disease and Its Predictors in a Chinese Population
Minrui Li et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy
Marcelo R. Luizon et al.
HYPERTENSION RESEARCH (2015)
An exon variant in insulin receptor gene is associated with susceptibility to colorectal cancer in women
Touraj Mahmoudi et al.
TUMOR BIOLOGY (2015)
The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity
V. A. Belo et al.
INTERNATIONAL JOURNAL OF OBESITY (2015)
Parathyroid Hormone Gene rs6256 and Calcium Sensing Receptor Gene rs1801725 Variants are not Associated with Susceptibility to Colorectal Cancer in Iran
Touraj Mahmoudi et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease
Sanja Stojsavljevic et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Resistin-420C>G promoter variant and colorectal cancer risk
Touraj Mahmoudi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2014)
Visfatin and its genetic variants are associated with obesity-related morbidities and cardiometabolic risk in severely obese children
S. Q. Ooi et al.
PEDIATRIC OBESITY (2014)
Alanine aminotransferase/aspartate aminotransferase ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults
Ryuichi Kawamoto et al.
CARDIOVASCULAR DIABETOLOGY (2012)
Annotation of functional variation in personal genomes using RegulomeDB
Alan P. Boyle et al.
GENOME RESEARCH (2012)
Visfatin Levels in Nonalcoholic Fatty Liver Disease
Erdem Akbal et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2012)
The-4817 G>A (rs2238136) variant of the vitamin D receptor gene: a probable risk factor for colorectal cancer
Touraj Mahmoudi et al.
MOLECULAR BIOLOGY REPORTS (2012)
The role of vascular endothelial growth factor+405 G/C polymorphism and albuminuria in patients with type 2 diabetes mellitus
Abdolrahim Nikzamir et al.
MOLECULAR BIOLOGY REPORTS (2012)
Skeletal muscle NAMPT is induced by exercise in humans
Sheila R. Costford et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
Epidemiology of Non-Alcoholic Fatty Liver Disease
Stefano Bellentani et al.
DIGESTIVE DISEASES (2010)
A Rare Variant in the Visfatin Gene (NAMPT/PBEF1) Is Associated With Protection From Obesity
Alexandra I. F. Blakemore et al.
OBESITY (2009)
The-1535 promoter variant of the visfatin gene is associated with serum triglyceride and HDL-cholesterol levels in Japanese subjects
Ayumi Tokunaga et al.
ENDOCRINE JOURNAL (2008)
Adipokines and cytokines in non-alcoholic fatty liver disease
M. H. Jarrar et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Nonalcoholic fatty liver disease in severely obese subjects
Pierre M. Gholam et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
A visfatin promoter polymorphism is associated with low-grade inflammation and type 2 diabetes
Yuan-Yuan Zhang et al.
OBESITY (2006)
Common polymorphisms in the promoter of the visfatin gene (PBEF1) influence plasma insulin levels in a French-Canadian population
Swneke D. Bailey et al.
DIABETES (2006)
Identification of a new human mtDNA polymorphism (A14290G) in the NADH dehydrogenase subunit 6 gene
M. Houshmand et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2006)
Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease
Yuichiro Eguchi et al.
JOURNAL OF GASTROENTEROLOGY (2006)
Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease
JW Haukeland et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2005)
Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury
SQ Ye et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes
B Vozarova et al.
DIABETES (2002)
Share Paper
